These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 38822912)

  • 1. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update.
    Jahandar-Lashaki S; Farajnia S; Faraji-Barhagh A; Hosseini Z; Bakhtiyari N; Rahbarnia L
    Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38822912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.
    Bakhshinejad B; Zade HM; Shekarabi HS; Neman S
    Amino Acids; 2016 Dec; 48(12):2699-2716. PubMed ID: 27650972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased selection of propagation-related TUPs from phage display peptide libraries.
    Zade HM; Keshavarz R; Shekarabi HSZ; Bakhshinejad B
    Amino Acids; 2017 Aug; 49(8):1293-1308. PubMed ID: 28664268
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    André AS; Moutinho I; Dias JNR; Aires-da-Silva F
    Front Microbiol; 2022; 13():962124. PubMed ID: 36225354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.
    Krumpe LR; Mori T
    Int J Pept Res Ther; 2006 Mar; 12(1):79-91. PubMed ID: 19444323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display derived peptides for Alzheimer's disease therapy and diagnosis.
    Zhang X; Zhang X; Gao H; Qing G
    Theranostics; 2022; 12(5):2041-2062. PubMed ID: 35265198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
    Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
    Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library.
    Sahin D; Taflan SO; Yartas G; Ashktorab H; Smoot DT
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):927-932. PubMed ID: 29693344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation Capacity of Phage Display Peptide Libraries Is Affected by the Length and Conformation of Displayed Peptide.
    Kamstrup Sell D; Sinkjaer AW; Bakhshinejad B; Kjaer A
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display: concept, innovations, applications and future.
    Pande J; Szewczyk MM; Grover AK
    Biotechnol Adv; 2010; 28(6):849-58. PubMed ID: 20659548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel colon adenocarcinoma cell targeting peptide using phage display library biopanning.
    Bakhshinejad B; Sadeghizadeh M
    Biotechnol Appl Biochem; 2022 Dec; 69(6):2753-2765. PubMed ID: 35103339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Screening of Peptide-Based Biotechnological Drug Candidates for Neurodegenerative Diseases Using Yeast Display and Phage Display.
    Özçelik CE; Beğli Ö; Hınçer A; Ahan RE; Kesici MS; Oğuz O; Kasırga TS; Özçubukçu S; Şeker UÖŞ
    ACS Chem Neurosci; 2023 Oct; 14(19):3609-3621. PubMed ID: 37638647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics.
    Sioud M
    Mol Biotechnol; 2019 Apr; 61(4):286-303. PubMed ID: 30729435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy.
    França RKA; Studart IC; Bezerra MRL; Pontes LQ; Barbosa AMA; Brigido MM; Furtado GP; Maranhão AQ
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage display technology: clinical applications and recent innovations.
    Azzazy HM; Highsmith WE
    Clin Biochem; 2002 Sep; 35(6):425-45. PubMed ID: 12413604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
    Alfaleh MA; Alsaab HO; Mahmoud AB; Alkayyal AA; Jones ML; Mahler SM; Hashem AM
    Front Immunol; 2020; 11():1986. PubMed ID: 32983137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring shark VNAR antibody against infectious diseases using phage display technology.
    Lim HT; Kok BH; Leow CY; Leow CH
    Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is phage display technology on target for developing peptide-based cancer drugs?
    Landon LA; Zou J; Deutscher SL
    Curr Drug Discov Technol; 2004 Jun; 1(2):113-32. PubMed ID: 16472251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of phage-displayed antibodies with high affinity and specificity by electrophoresis in microfluidic devices.
    Sanluis-Verdes A; Peñaherrera A; Torán JL; Rosero G; Noriega MA; Lerner B; Pérez M; Casasnovas JM
    Electrophoresis; 2023 May; 44(9-10):864-872. PubMed ID: 36932828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage display screening of therapeutic peptide for cancer targeting and therapy.
    Saw PE; Song EW
    Protein Cell; 2019 Nov; 10(11):787-807. PubMed ID: 31140150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.